Analysis of Elemental Impurities in Medium- chain Triglycerides According to USP
Applications
| 2022 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS
Applications
| 2023 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS
Applications
| 2021 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>
Applications
| 2015 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Analysis of Artificial Tear Eye Drops For Elemental Impurities
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030
Applications
| 2019 | Shimadzu
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Shimadzu
Industries
Pharma & Biopharma
Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>
Applications
| 2022 | Thermo Fisher Scientific
ICP/MS, ICP/OES
Instrumentation
ICP/MS, ICP/OES
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma
Determination of Extractable and Leachable Elements Using ICP-MS
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030